# Elisabetta Bugianesi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/elisabetta-bugianesi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 77,366 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 115 |
| i10-index | 307 |
| Last Known Institution | Department of Medical Sciences |
| OpenAlex ID | https://openalex.org/A5039389628 |
| ORCID iD | 0000-0002-0502-4381 |
| Works | 677 |

## Researcher papers

Showing 12 of 32.

- [Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention](https://scholariq.org/papers/global-burden-of-nafld-and-nash-trends-predictions-risk-factors-and-prevention/)
- [A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement](https://scholariq.org/papers/a-new-definition-for-metabolic-dysfunction-associated-fatty-liver-disease-an/)
- [MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease](https://scholariq.org/papers/mafld-a-consensus-driven-proposed-nomenclature-for-metabolic-associated-fatty/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-3/)
- [Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome](https://scholariq.org/papers/nonalcoholic-fatty-liver-steatohepatitis-and-the-metabolic-syndrome/)
- [Nonalcoholic Fatty Liver Disease](https://scholariq.org/papers/nonalcoholic-fatty-liver-disease/)
- [Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis](https://scholariq.org/papers/global-perspectives-on-nonalcoholic-fatty-liver-disease-and-nonalcoholic/)
- [EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)](https://scholariq.org/papers/easl-easd-easo-clinical-practice-guidelines-on-the-management-of-metabolic/)
- [Association of nonalcoholic fatty liver disease with insulin resistance](https://scholariq.org/papers/association-of-nonalcoholic-fatty-liver-disease-with-insulin-resistance/)
- [NASH limits anti-tumour surveillance in immunotherapy-treated HCC](https://scholariq.org/papers/nash-limits-anti-tumour-surveillance-in-immunotherapy-treated-hcc/)
- [Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial](https://scholariq.org/papers/obeticholic-acid-for-the-treatment-of-non-alcoholic-steatohepatitis-interim/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Diet, Metabolism, and Disease](https://scholariq.org/topics/diet-metabolism-and-disease/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Department of Medical Sciences](https://scholariq.org/institutions/department-of-medical-sciences-3/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.